Hepatitis C prophylactic vaccine - Innogenetics
Alternative Names: ED 001Latest Information Update: 02 Oct 2021
At a glance
- Originator Innogenetics
- Class Hepatitis C vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis C
Most Recent Events
- 15 Jan 2003 Preclinical trials in Hepatitis C prevention in Belgium (unspecified route)